Trial Profile
Phase I trial of NBI 98854 in male volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 24 Jul 2017
Price :
$35
*
At a glance
- Drugs Valbenazine (Primary)
- Indications Drug-induced dyskinesia
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Neurocrine Biosciences